Association of statin and nonsteroidal anti‐inflammatory drug use with prostate cancer outcomes: results from CaPSURE
- 13 August 2010
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 106 (5), 627-632
- https://doi.org/10.1111/j.1464-410x.2010.09232.x
Abstract
To determine whether 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with the risk of prostate cancer and improved survival in men with prostate cancer. We retrospectively examined the association between NSAID and statin use among 7042 men who underwent radical prostatectomy (RP, 4611) or radiotherapy (RT, 2431) for prostate cancer between 1990 and 2003 identified in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a primarily community-based national prostate cancer registry. We compared clinical and sociodemographic variables by statin and NSAID use, using chi-square tests and multinomial logistic regression. We examined associations between medications and comorbid illness with mortality using unadjusted and adjusted Cox proportional hazard models. The median (range) follow-up from treatment was 4 (0-16) years. In multivariate survival analysis, statin 'ever-use' was associated with a reduced risk of all-cause mortality (ACM) after RP (hazard ratio, HR, 0.35, 95% confidence interval, CI, 0.21-0.58) and RT (0.59, 0.37-0.94). NSAID ever-use was also associated with a reduced risk of ACM after RP (HR 0.47, 95% CI 0.30-0.75) and RT (0.39, 0.25-0.59). In a population of men with prostate cancer, statin and NSAID ever-use were associated with a reduced risk of ACM. Our study highlights the importance of multidisciplinary survivorship care for men with prostate cancer.Keywords
This publication has 23 references indexed in Scilit:
- Statins for Secondary Prevention in Elderly Patients: A Hierarchical Bayesian Meta-AnalysisJournal of the American College of Cardiology, 2008
- Statin Drugs and Risk of Advanced Prostate CancerJNCI Journal of the National Cancer Institute, 2006
- The Epidemiology of Prostate Cancer—with a Focus on Nonsteroidal Anti-inflammatory DrugsHematology/Oncology Clinics of North America, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Nonsteroidal Anti-inflammatory Drugs and Risk of Prostate Cancer in the Baltimore Longitudinal Study of AgingCancer Epidemiology, Biomarkers & Prevention, 2005
- Therapy Insight: potential of statins for cancer chemoprevention and therapyNature Clinical Practice Oncology, 2005
- The Statins: Multifunctional Antithrombotic and Antineoplastic DrugsSeminars in Thrombosis and Hemostasis, 2003
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- The Impact of Co-morbidity on Life Expectancy Among Men with Localized Prostate CancerJournal of Urology, 1996